Developer docs
API playgroundTry for free, no card

Search company profiles

Copan Group

Full company profile

uuid0009d2q

Namestring
Copan Group
Legal namestring
Copan Italia S.p.A.
Websiteurl
copangroup.com
Company typeenum
Private
Founded yearint
1979
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBrescia, Italy
HQ citystring
Brescia
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical microbiology products, sample collection devices, laboratory automation systems, preanalytical solutions, microbiology consumables
Industry6 codes
1Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
CodeHLAHAAANPrimaryYes
2Microbiology & Infectious Disease Testing Laboratories
CodeHLAFAMADPrimaryNo
3Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
CodeHLAAALACPrimaryNo
4Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
CodeHLAGADAEPrimaryNo
5Environmental Monitoring & Cleanroom Testing (GMP)
CodeHLAGADALPrimaryNo
6Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes)
CodeIMALAIAFPrimaryNo
NAICS code4 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Clinical Microbiology & Laboratory Diagnostics Equipment
Social media profiles4 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Clinical Preanalytics Products
TypeHardware Sales
Description

Sale of FLOQSwabs, collection and transport media (UTM, eNAT, eSwab, MSwab, FecalSwab), and related consumables for clinical microbiology sample collection and preservation.

copangroup.com
2Clinical Laboratory Automation
TypeHardware Sales
Description

Sale and service of laboratory automation equipment including WASPLab, WASP, Radian, PhenoMATRIX, Colibri, MicroHub, HEMO, and WASP-FLO systems for clinical microbiology laboratories.

copangroup.com
3Industrial Automation
TypeHardware Sales
Description

Sale of Cyclone and PharmaLab automation systems for quality control in food, cosmetics, and pharmaceutical industries.

copangroup.com
4Business Alliances and OEM
TypeProfessional Services
Description

Customization services, OEM production partnerships, and regulatory support for diagnostic kit manufacturers and other business partners.

copangroup.com
5Industrial Consumables
TypeHardware Sales
Description

SRK swab rinse kits, MediaBag ready-to-use media, and other products for environmental monitoring in industrial settings.

copangroup.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 19 records shown
1FLOQSwabs
Description

Patented flocked swab technology with perpendicular Nylon fibers for superior sample collection and elution

copangroup.com
+18 more records
Core offering1 text field

Copan Group designs, manufactures, and sells preanalytical sample collection and transport devices (flocked swabs, transport media) along with automated laboratory systems (specimen processors, incubators, AI-powered image analysis software) for clinical microbiology laboratories and industrial quality control operations in pharmaceutical, food, and cosmetics industries. The integrated ecosystem spans from sample collection through digitization and AI-assisted interpretation of bacteriology plates.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • PhenoMATRIX FDA 510(k) clearance enables AI-powered sorting of bacterial culture plate images for clinical microbiology labs in the US market
+2 more records
Product overview1 text field

Copan Group offers a comprehensive portfolio of sample collection, transport, and laboratory automation solutions organized into two main categories: Consumables (collection/transport devices) and Automation systems. The consumables portfolio includes FLOQSwabs® (flocked swab technology), liquid-based microbiology media (eSwab®, UTM®, eNAT®, FecalSwab®, MSwab®, UBM™), enrichment broths (LBM® Broths including CABroth), specialized collection devices (UriSponge™, MycoTB™, Self-LolliSponge™, SMART-eNAT®), and forensic/genetics products (4N6FLOQSwabs®, microFLOQ®, NUCLEIC-CARD™). The automation ecosystem (WISE approach) integrates WASP® specimen processing, WASPLab® incubation/digitization, Radian® disk diffusion automation, PhenoMATRIX® AI interpretation, Colibrí™ colony picking, MicroHub® middleware, WASP-FLO™ sorting, HEMO™ blood culture processing, UniVerse® molecular preparation, and industrial solutions Cyclone™ and PharmaLab™ for quality control.

Product and service3 records
1FLOQSwabs®
CategorySample Collection Devices
Description

Patented flocked swab technology featuring perpendicular Nylon® fibers for optimal adsorption and rapid sample release. Gold standard for biological sampling across clinical and forensic applications.

2eSwab®
CategorySample Collection Devices
Description

Multipurpose collection and transport system for aerobes, anaerobes, fastidious bacteria, viruses, and Chlamydia. Enables culture, Gram stain, antigen detection, and molecular assays from a single sample.

3UTM® (Universal Transport Medium)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierNotableTypeStrategic or Co-development PartnerAnnounced on2025-03-07
Description

BAMOS AG uses Copan's Cyclone automation system for food safety testing. CEO Patrick Wirth provided testimonial on transformative impact of Cyclone on operational efficiency and consistency in an exclusive interview.

Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-10-01
Description

Mekalasi Oy, Copan's partner in Scandinavia, accomplished installing the first two Colibri picking automation systems in Scandinavia at Helsinki HUS Diagnostic Center.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major clinical lab automation and diagnostics player within Danaher, offering sample processing, microbiology, and lab informatics competing with Copan's WISE ecosystem. Strong installed base in hospital core labs and broad menu that Copan does not match.

TypeDirect peer
Description

Owns the MALDI Biotyper and microbiology workflow platforms, and partners with Copan's Colibri colony picker for MALDI-TOF target prep. Direct overlap in microbial identification and automated culture workflows in clinical microbiology labs.

TypeRegional player
Description

Major Chinese IVD and microbiology automation provider competing in Asia-Pacific clinical and industrial microbiology markets where Copan operates via its Shanghai subsidiary. Comparable product categories in automation and immunoassays, primarily competing regionally rather than globally.

TypeBroad incumbent
Description

Global provider of sample preparation, molecular testing, and lab automation technologies, with overlap to Copan's eNAT/UniVerse molecular workflow products. Broader molecular menu and stronger pharma/biopharma relationships, but Copan competes in collection/transport upstream.

TypeDirect peer
Description

Leading US manufacturer of single-use specimen collection devices, including flocked and foam swabs that compete directly with Copan's FLOQSwabs. Closely comparable product line and customer base in clinical diagnostics and forensics.

TypeDirect peer
Description

US-based manufacturer of culture media, sample collection/transport devices, and laboratory supplies serving clinical and industrial microbiology labs. Highly comparable to Copan's consumables and prepared-media business, though with less automation depth.

TypeBroad incumbent
Description

French in vitro diagnostics leader focused on clinical microbiology, industrial microbiology QC, and molecular diagnostics, with products like VITEK and BioBall competing head-to-head with Copan's WASPLab and culture interpretation stack. Direct overlap in specimen processing, AST automation, and pharma/food QC.

TypeBroad incumbent
Description

Global medical technology giant with a leading Diagnostics segment spanning sample collection (ESwab competitor), microbiology automation (BD Kiestra), and laboratory consumables. Directly comparable to Copan across preanalytics and clinical lab automation, but with a vastly broader portfolio and deeper hospital relationships.

TypeEmerging player
Description

Diagnostics company with growing molecular and women's health testing menus; Panther system and Aptima collection/transport devices compete with parts of Copan's eNAT/UTM and UniVerse molecular prep portfolio. Less direct overlap in culture automation.

TypeBroad incumbent
Description

Remel is Thermo Fisher's clinical microbiology brand offering culture media, identification, and AST products. Direct overlap with Copan's clinical microbiology consumables and overlapping industrial QC offerings under Thermo Fisher's broader diagnostics umbrella.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Copan Group

Clinical Microbiology & Laboratory Diagnostics Equipmentcopangroup.com

Copan Group firmographics

Firmographics
Name
Copan Group
Legal name
Copan Italia S.p.A.
Website
https://copangroup.com
Company type
Private
Founded year
1979
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Copan Group industry classification

Industry
Product category
Clinical Microbiology & Laboratory Diagnostics Equipment
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
akta.pro secondary industries
Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE), Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL), Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes) (IMALAIAF)

Keywords

  • Clinical microbiology products
  • Sample collection devices
  • Laboratory automation systems
  • Preanalytical solutions
  • Microbiology consumables

Where Copan Group is headquartered

Location

Headquarters

HQ city
Brescia
HQ country
Italy
HQ region
Europe

Offices7 records

Markets served

Copan Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Preanalytics Products: Sale of FLOQSwabs, collection and transport media (UTM, eNAT, eSwab, MSwab, FecalSwab), and related consumables for clinical microbiology sample collection and preservation.
  2. Clinical Laboratory Automation: Sale and service of laboratory automation equipment including WASPLab, WASP, Radian, PhenoMATRIX, Colibri, MicroHub, HEMO, and WASP-FLO systems for clinical microbiology laboratories.
  3. Industrial Automation: Sale of Cyclone and PharmaLab automation systems for quality control in food, cosmetics, and pharmaceutical industries.
  4. Business Alliances and OEM: Customization services, OEM production partnerships, and regulatory support for diagnostic kit manufacturers and other business partners.
  5. Industrial Consumables: SRK swab rinse kits, MediaBag ready-to-use media, and other products for environmental monitoring in industrial settings.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Copan Group product offering

Product offering

Core offering

Copan Group designs, manufactures, and sells preanalytical sample collection and transport devices (flocked swabs, transport media) along with automated laboratory systems (specimen processors, incubators, AI-powered image analysis software) for clinical microbiology laboratories and industrial quality control operations in pharmaceutical, food, and cosmetics industries. The integrated ecosystem spans from sample collection through digitization and AI-assisted interpretation of bacteriology plates.

Product overview

Copan Group offers a comprehensive portfolio of sample collection, transport, and laboratory automation solutions organized into two main categories: Consumables (collection/transport devices) and Automation systems. The consumables portfolio includes FLOQSwabs® (flocked swab technology), liquid-based microbiology media (eSwab®, UTM®, eNAT®, FecalSwab®, MSwab®, UBM™), enrichment broths (LBM® Broths including CABroth), specialized collection devices (UriSponge™, MycoTB™, Self-LolliSponge™, SMART-eNAT®), and forensic/genetics products (4N6FLOQSwabs®, microFLOQ®, NUCLEIC-CARD™). The automation ecosystem (WISE approach) integrates WASP® specimen processing, WASPLab® incubation/digitization, Radian® disk diffusion automation, PhenoMATRIX® AI interpretation, Colibrí™ colony picking, MicroHub® middleware, WASP-FLO™ sorting, HEMO™ blood culture processing, UniVerse® molecular preparation, and industrial solutions Cyclone™ and PharmaLab™ for quality control.

Differentiator

Problem solved

Functional benefit

Brands

  • FLOQSwabs: Patented flocked swab technology with perpendicular Nylon fibers for superior sample collection and elution
  • WASPLab
  • WASP
  • PhenoMATRIX
  • Radian
  • Colibri
  • UniVerse
  • MicroHub
  • HEMO
  • Cyclone
  • PharmaLab
  • LBM (Liquid Based Microbiology)
  • eNAT
  • eSwab
  • UTM (Universal Transport Medium)
  • FecalSwab
  • MSwab
  • UriSponge
  • Futura Invent

Products and services

  • FLOQSwabs® Patented flocked swab technology featuring perpendicular Nylon® fibers for optimal adsorption and rapid sample release. Gold standard for biological sampling across clinical and forensic applications.
  • eSwab® Multipurpose collection and transport system for aerobes, anaerobes, fastidious bacteria, viruses, and Chlamydia. Enables culture, Gram stain, antigen detection, and molecular assays from a single sample.
  • UTM® (Universal Transport Medium)

Quantifiable outcome

  • PhenoMATRIX FDA 510(k) clearance enables AI-powered sorting of bacterial culture plate images for clinical microbiology labs in the US market
  • +2 more outcomes

Companies that use Copan Group

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles4 records

Copan Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Copan Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered notable and regional.

  • BAMOS AGnotableStrategic or Co-development Partner · 7 March 2025BAMOS AG uses Copan's Cyclone automation system for food safety testing. CEO Patrick Wirth provided testimonial on transformative impact of Cyclone on operational efficiency and consistency in an exclusive interview.
  • Mekalasi OyregionalChannel Partner/ Reseller/ Distributor · 1 October 2024Mekalasi Oy, Copan's partner in Scandinavia, accomplished installing the first two Colibri picking automation systems in Scandinavia at Helsinki HUS Diagnostic Center.

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

Copan Group competitors and assessment

Company assessment

Broad incumbents

  • Beckman Coulter (Danaher): Major clinical lab automation and diagnostics player within Danaher, offering sample processing, microbiology, and lab informatics competing with Copan's WISE ecosystem. Strong installed base in hospital core labs and broad menu that Copan does not match.
  • QIAGEN: Global provider of sample preparation, molecular testing, and lab automation technologies, with overlap to Copan's eNAT/UniVerse molecular workflow products. Broader molecular menu and stronger pharma/biopharma relationships, but Copan competes in collection/transport upstream.
  • bioMérieux: French in vitro diagnostics leader focused on clinical microbiology, industrial microbiology QC, and molecular diagnostics, with products like VITEK and BioBall competing head-to-head with Copan's WASPLab and culture interpretation stack. Direct overlap in specimen processing, AST automation, and pharma/food QC.
  • Becton, Dickinson and Company (BD): Global medical technology giant with a leading Diagnostics segment spanning sample collection (ESwab competitor), microbiology automation (BD Kiestra), and laboratory consumables. Directly comparable to Copan across preanalytics and clinical lab automation, but with a vastly broader portfolio and deeper hospital relationships.
  • Remel (Thermo Fisher Scientific): Remel is Thermo Fisher's clinical microbiology brand offering culture media, identification, and AST products. Direct overlap with Copan's clinical microbiology consumables and overlapping industrial QC offerings under Thermo Fisher's broader diagnostics umbrella.

Direct peers

  • Bruker Corporation: Owns the MALDI Biotyper and microbiology workflow platforms, and partners with Copan's Colibri colony picker for MALDI-TOF target prep. Direct overlap in microbial identification and automated culture workflows in clinical microbiology labs.
  • Puritan Medical Products: Leading US manufacturer of single-use specimen collection devices, including flocked and foam swabs that compete directly with Copan's FLOQSwabs. Closely comparable product line and customer base in clinical diagnostics and forensics.
  • Hardy Diagnostics: US-based manufacturer of culture media, sample collection/transport devices, and laboratory supplies serving clinical and industrial microbiology labs. Highly comparable to Copan's consumables and prepared-media business, though with less automation depth.

Regional players

  • Autobio Diagnostics: Major Chinese IVD and microbiology automation provider competing in Asia-Pacific clinical and industrial microbiology markets where Copan operates via its Shanghai subsidiary. Comparable product categories in automation and immunoassays, primarily competing regionally rather than globally.

Emerging players

  • Hologic: Diagnostics company with growing molecular and women's health testing menus; Panther system and Aptima collection/transport devices compete with parts of Copan's eNAT/UTM and UniVerse molecular prep portfolio. Less direct overlap in culture automation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Copan Group social profiles

Digital presence

Copan Group compliance and trust

Trust signal

Compliance5 records

Copan Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Copan Group leadership team

Management profile

Number of profiles

Profiles1 record

Copan Group subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Copan Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Copan Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Copan Group

What does Copan Group do?

Copan Group designs, manufactures, and sells preanalytical sample collection and transport devices (flocked swabs, transport media) along with automated laboratory systems (specimen processors, incubators, AI-powered image analysis software) for clinical microbiology laboratories and industrial quality control operations in pharmaceutical, food, and cosmetics industries. The integrated ecosystem spans from sample collection through digitization and AI-assisted interpretation of bacteriology plates.

Is Copan Group a public or private company?

Copan Group is a private company. It is classified as family owned and is currently operating.

When was Copan Group founded?

Copan Group was founded in 1979. It employs 1,001 to 5,000 people.

Where is Copan Group based?

Copan Group is headquartered in Brescia, Italy, in the Europe region.

How does Copan Group make money?

Five revenue lines are on record. Clinical Preanalytics Products are the primary driver. The others are clinical Laboratory Automation, industrial Automation, business Alliances and OEM and industrial Consumables.

Who are Copan Group's main competitors?

Broad incumbents on record are Beckman Coulter (Danaher), QIAGEN, bioMérieux, Becton, Dickinson and Company (BD) and Remel (Thermo Fisher Scientific). Direct peers are Bruker Corporation, Puritan Medical Products and Hardy Diagnostics. Autobio Diagnostics is listed as a regional player. Hologic is listed as an emerging player.

Does Copan Group have an API?

No public API is recorded for Copan Group.

What industry is Copan Group in?

Copan Group's product category is Clinical Microbiology & Laboratory Diagnostics Equipment. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFDA 510(k) Clearance Establishes Broad Intended Use for Copan's PhenoMATRIX®, Expanding Clinical Microbiology CapabilitiesCopan Group announced that its PhenoMATRIX® automated image assessment software received FDA 510(k) clearance as a Class II device in the United States, formalizing the intended use of the AI-powered system for clinical microbiology labs. The clearance enables the software to work with multiple culture media plate types including blood-based, chocolate, MacConkey agars, and CHROMagar orientation plates for microbial growth detection, colony count estimation, and isolate differentiation. While PhenoMATRIX has been used globally for years as part of Copan's full laboratory automation solutions, this clearance formally establishes its commercial deployment in the U.S., with final image assessment and result decisions performed by trained laboratory personnel.BioSpaceFDA 510(k) Clearance Establishes Broad Intended Use for Copan’s PhenoMATRIX®, Expanding Clinical Microbiology CapabilitiesCopan Group announced that its PhenoMATRIX® automated image assessment software received FDA 510(k) clearance as a Class II in vitro diagnostic device in the United States. The clearance enables the AI-powered software, which integrates with WASPLab® full laboratory automation, to support multiple culture media plate types including blood-based, chocolate, MacConkey agars, and CHROMagar orientation for automated microbial growth detection and colony analysis. While PhenoMATRIX has been used globally outside the US for years, this clearance formally establishes its intended use in the US clinical microbiology market, where trained laboratory personnel retain oversight of final image assessment and result decisions.PR NewswireFDA 510(k) Clearance Establishes Broad Intended Use for Copan's PhenoMATRIX®, Expanding Clinical Microbiology CapabilitiesCopan Group announced that its PhenoMATRIX automated image assessment software received FDA 510(k) clearance as a Class II in vitro diagnostic device in the United States. The software uses artificial intelligence to automatically sort images of bacterial culture plates across multiple media types, including blood-based, chocolate, MacConkey, and CHROMagar orientation agars. Copan plans to pursue additional submissions to expand PhenoMATRIX across further applications and plate types.NewswireFDA 510(k) Clearance Establishes Broad Intended Use for Copan's PhenoMATRIX®, Expanding Clinical Microbiology CapabilitiesCopan Group announced on February 17, 2026, that its PhenoMATRIX® automated image assessment software received FDA 510(k) clearance as a Class II medical device in the United States, enabling AI-powered sorting of bacterial culture plate images for clinical microbiology laboratories. The clearance formally establishes the software's intended use in the U.S., supporting multiple culture media plate types including blood-based, chocolate, MacConkey, and CHROMagar agars, with final assessments performed by trained laboratory personnel. Copan stated it will continue investing in future regulatory submissions to expand PhenoMATRIX across additional applications and plate types.PR NewswireCopan Expands U.S. Manufacturing Footprint with Multimillion-Dollar InvestmentCopan Diagnostics, part of Italy-based Copan Group, announced a multimillion-dollar investment exceeding $5 million to expand U.S. manufacturing at its California and Puerto Rico facilities. The investment includes new production of UriSponge® devices, increased U.S. component and reagent sourcing, and a new centralized quality assurance laboratory, with construction beginning this month and operations projected to launch in Q1 2026. The expansion aims to reduce reliance on overseas supply chains and strengthen supply chain resilience for U.S. laboratories.PR NewswirePuritan obtiene otra victoria legal contra Copan en SueciaThe Swedish Court of Appeal has upheld a previous ruling that Puritan Medical Products' flocked swabs do not infringe on patents held by Italian competitor Copan Italia S.p.A., marking Copan's sixth consecutive legal defeat in patent disputes. This victory reinforces Puritan's intellectual property position and clears the way for continued operations without infringement liability in Sweden. The article notes that Copan has lost similar cases in Germany and the United States, highlighting a consistent pattern of failed litigation against the industry.PR NewswirePuritan Secures Another Legal Victory Against Copan in SwedenThe Swedish Court of Appeals has affirmed that Puritan Medical Products' flocked swabs do not infringe any claims of Copan Italia S.p.A.'s European Patent, marking Puritan's sixth legal victory against the Italian competitor in patent infringement lawsuits. Copan originally filed the Swedish lawsuit against Puritan's distributor Svenska LABFAB in April 2019 after losing a competitive bid, but courts sided with LABFAB by June 2020, with legal fees also awarded to the distributor. The ruling adds to Puritan's streak of wins, including similar victories in German lawsuits and appeals in November 2020 and a defeat of Copan's claims at the International Trade Commission in Washington, D.C. in 2022.FrontiersCopan Walk Away Specimen Processor (WASP) Automated System for Pathogen Detection in Female Reproductive Tract SpecimensA study compared the Copan WASP automated system to manual culture for detecting pathogens in female reproductive tract specimens. The automated system detected fewer bacterial types and colonies but had a higher single-colony detection rate, with no significant difference in common pathogens like GBS and Candida. Further validation is needed for Ureaplasma urealyticum and Neisseria gonorrhoeae.PR NewswirePensando en el futuro: Copan anuncia un importante cambio de imagen y presenta su nuevo sitio webCopan, an Italian preanalytical solutions company based in Brescia, announced the completion of a comprehensive brand refresh initiative, unveiling a new logo and redesigned website at www.copangroup.com. The rebranding project was originally planned for the company's 40th anniversary in 2019 but was postponed due to the COVID-19 pandemic. The new brand identity includes updated graphic design and communication strategy, while retaining the slogan "Innovar juntos" (Innovate Together), reflecting the company's core values of innovation and partnership.PR NewswireAvanzando: Copan anuncia un importante cambio de marca y lanza un nuevo sitio webCopan, an Italian preanalytics company based in Brescia, announced the completion of a comprehensive rebranding initiative including a new logo and website, originally planned for their 40th anniversary in 2019 but postponed due to the pandemic. The company reached its goal of producing 2 billion swabs per year during COVID-19 and is now stabilizing supply of pandemic-related products while moving forward with its new identity. The rebranding features updated communication strategy, graphic design, and a new website at www.copangroup.com featuring optimized navigation for global product and service information access.